Procainamide (PA) induces the production of a number of autoantibodies in a high proportion of treated individuals and in some a syndrome closely resembling systemic lupus erythematosus. The mechanism underlying this action of PA is unclear. To examine the possibility that PA might induce autoantibody formation by altering normal immunoregulatory mechanisms, the action of this drug on an in vitro model of antibody formation in man was examined. PA was found to augment the generation of immunoglobulin-secreting cells (ISC) from human peripheral blood mononuclear cells (PBM) in response to pokeweed mitogen but had no effect on pokeweed mitogen-induced tritiated thymidine incorporation. When purified populations of B and T cells were used, PA enhanced the generation of ISC in B-cell cultures supported by untreated T cells but not by T cells treated with mitomycin C. These results indicate that PA augmented B-cell responses by inhibiting suppressor T-cell activity and not by augmenting helper T-cell or B-cell function. N-Acetyl-procainamide had no effect on the generation of ISC in this system. The effect of PA on concanavalin A (Con A)-induced suppressor cell activity was also examined to determine whether PA altered the generation or expression of suppressor T-cell function. PBM were cultured with 30 microgram/ml of Con A for 48 h to generate suppressor cells. When these were co-cultured with fresh PBM, the number of ISC generated was decreased by 58.1 +/- 3.4% (mean +/- SEM, n = 6). Cells that had been similarly incubated without Con A were not inhibitory. The addition of PA to the Con A-stimulated cultures inhibited the generation of suppressor cells as indicated by the fact that the response of fresh cells co-cultured with the Con A-stimulated cells was diminished by only 27.2 +/- 4.3%. In this system too, N-acetyl-procaimamide had no effect. By contrast, adding PA only to the co-culture of Con A-stimulated cells with fresh PBM had a less marked effect on suppressor cell function. These results indicate that the major action of PA is to inhibit the generation of suppressor T-cell activity. Such an effect may explain the capacity of this agent to induce autoantibody formation in treated individuals.
T Ochi, E A Goldings, P E Lipsky, M Ziff
Title and authors | Publication | Year |
---|---|---|
Cutaneous histopathology of lupus erythematosus
AN Crowson, CM Magro |
Diagnostic Histopathology | 2009 |
Systemic Lupus Erythematosus
M Petri |
JCR: Journal of Clinical Rheumatology | 2006 |
The cutaneous pathology of lupus erythematosus: a review
AN Crowson, C Magro |
Journal of Cutaneous Pathology | 2001 |
Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy
AN Crowson, CM Magro |
Human Pathology | 1997 |
Quinidine-induced rheumatic syndromes
JA Alloway, MP Salata |
Seminars in Arthritis and Rheumatism | 1995 |
Effect of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the production of interleukin-4 from a clone of burn-associated CD8+ suppressor T cells
M Kobayashi, T Utsunomiya, DN Herndon, RB Pollard, F Suzuki |
Immunology Letters | 1994 |
DRUG-INDUCED LUPUS
RL Yung, BC Richardson |
Rheumatic diseases clinics of North America | 1994 |
The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production
G Garratty, P Arndt, HE Prince, IA Shulman |
British Journal of Haematology | 1993 |
Drug-Induced Autoimmune Hemolytic Anemia
LD Petz |
Transfusion Medicine Reviews | 1993 |
Study of procainamide hapten-specific antibodies in rabbits and humans
LE Adams, SM Roberts, R Donovan-Brand, H Zimmer, EV Hess |
International Journal of Immunopharmacology | 1993 |
The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug Reactions
JP Uetrecht |
Drug Metabolism Reviews | 1992 |
TheIn VltroandIn VivoEffects of 1.1–Dimethylhydrazine (Udmh) On Murine Lymphocyte Subsets and Ia Antigen Expression
DE Frazier, MJ Tarr, RG Olsen |
Immunopharmacology and Immunotoxicology | 1991 |
Drug-related lupus syndromes and their relationship to spontaneously occurring systemic lupus erythematosus
D Alarcón-Segovia, A Kraus |
Baillière's Clinical Rheumatology | 1991 |
Drug-Related Lupus: Incidence, Mechanisms and Clinical Implications
LE Adams, EV Hess |
Drug Safety | 1991 |
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat
CD Pusey, C Bowman, A Morgan, AP Weetman, B Hartley, CM Lockwood |
Clinical & Experimental Immunology | 1990 |
Immunotoxic Side-Effects of Drug Therapy:
JA Mitchell, EM Gillam, LA Stanley, E Sim |
Drug Safety | 1990 |
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat.
Pusey CD, Bowman C, Morgan A, Weetman AP, Hartley B, Lockwood CM |
Clinical & Experimental Immunology | 1990 |
Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro
RL Rubin, JT Curnutte |
Journal of Clinical Investigation | 1989 |
Defective Helper T Cell Function in IgM Rheumatoid Factor Synthesis in Patients with Ankylosing Spondylitis
CL Yu, KL Chang, ST Hong, BN Chiang, SH Han, SR Wang |
Scandinavian Journal of Rheumatology | 1989 |
Immunobiology of HLA
B Dupont |
1989 | |
Procainamide Induces a Transitory Impairment of b Cell Mitogenesis in Beagle Dogs
SA Mulhern, F Daguillard, CJ Robinson, T Balazs |
Drug and Chemical Toxicology | 1988 |
Autoimmunity induced by chemicals
PE Bigazzi |
Journal of Toxicology: Clinical Toxicology | 1988 |
POLYMORPHONUCLEAR CELL FACTOR FOUND IN PATIENTS WITH RHEUMATOID ARTHRITIS
S Wakitani, D Sakamuro, T Ochi, H Owaki, M Fujimoto, K Ono |
Biomedical Research | 1988 |
Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1)
J Gohill, MJ Fritzler |
Molecular Immunology | 1987 |
The origin of autoantibodies
A Schattner |
Immunology Letters | 1987 |
Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide
Y Shoenfeld, Y Vilner, T Reshef, A Klajman, A Skibin, O Kooperman, RC Kennedy |
Journal of Clinical Immunology | 1987 |
Specificity of Acebutolol-Induced Antinuclear Antibodies
S Querin, MN Feuillet-Fieux, L Jacob, G Niel, JF Bach |
Immunopharmacology and Immunotoxicology | 1986 |
Procainamide elicits a selective autoantibody immune response
RL Rubin, G Reimer, EM McNally, SR Nusinow, RP Searles, EM Tan |
Clinical & Experimental Immunology | 1986 |
Haematological Effects of Non-Narcotic Analgesics:
PA Miescher, W Pola |
Drugs | 1986 |
Effects of long-term procainamide therapy on immunoglobulin synthesis
CL Yu, M Ziff |
Arthritis & Rheumatism | 1985 |
Effects of L-canavanine on t cells may explain the induction of systemic lupus erythematosus by alfalfa
J Alcocer-varela, A Iglesias, L Llorente, D Alarcón-Segovia |
Arthritis & Rheumatism | 1985 |
Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups
G Boccardo, D Drayer, AL Rubin, A Novogrodsky, MM Reidenberg, KH Stenzel |
Clinical & Experimental Immunology | 1985 |
Drug-Induced Lupus: Clinical Spectrum and Pathogenesis
JJ Cush, EA Goldings |
The American Journal of the Medical Sciences | 1985 |
Drug-induced lupus: Genetic, clinical, and laboratory features
MC Totoritis, RL Rubin |
Postgraduate Medicine | 1985 |
PROCAINAMIDE AUGMENTS VACCINATION EFFECT
Y Aoki, N Wakamiya, T Ochi, S Ueda, S Kato, K Ono |
Biomedical Research | 1985 |
Immunology of Rheumatic Diseases
S Gupta, N Talal |
1985 | |
Captopril and immune regulation
JF Delfraissy, P Galanaud, JF Balavoine, C Wallon, J Dormont |
Kidney International | 1984 |
Immunologic and Genetic Factors in Autoimmune Diseases
Y Shoenfeld, RS Schwartz |
New England Journal of Medicine | 1984 |
Positive Direct Antiglobulin Tests and Immune Hemolytic Anemia in Patients Receiving Procainamide
S Kleinman, R Nelson, L Smith, D Goldfinger |
New England Journal of Medicine | 1984 |
Aromatic amines and the pathogenesis of lupus erythematosus
MM Reidenberg |
The American Journal of Medicine | 1983 |